LIDOCAINE - 51004-1051-5 - (Lidocaine Hydrochloride and Epinephrine Bitartrate)

Alphabetical Index


Drug Information of LIDOCAINE

Product NDC: 51004-1051
Proprietary Name: LIDOCAINE
Non Proprietary Name: Lidocaine Hydrochloride and Epinephrine Bitartrate
Active Ingredient(s): .01; 20    mg/mL; mg/mL & nbsp;   Lidocaine Hydrochloride and Epinephrine Bitartrate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of LIDOCAINE

Product NDC: 51004-1051
Labeler Name: Novocol Pharmaceutical of Canada, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA088390
Marketing Category: ANDA
Start Marketing Date: 20111107

Package Information of LIDOCAINE

Package NDC: 51004-1051-5
Package Description: 50 CARTRIDGE in 1 CARTON (51004-1051-5) > 1.7 mL in 1 CARTRIDGE

NDC Information of LIDOCAINE

NDC Code 51004-1051-5
Proprietary Name LIDOCAINE
Package Description 50 CARTRIDGE in 1 CARTON (51004-1051-5) > 1.7 mL in 1 CARTRIDGE
Product NDC 51004-1051
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lidocaine Hydrochloride and Epinephrine Bitartrate
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20111107
Marketing Category Name ANDA
Labeler Name Novocol Pharmaceutical of Canada, Inc.
Substance Name EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
Strength Number .01; 20
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient]

Complete Information of LIDOCAINE


General Information